Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5513
Source ID: NCT06203275
Associated Drug: Paroxetine
Title: The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
Acronym:
Status: NOT_YET_RECRUITING
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Paroxetine|DRUG: Placebo
Outcome Measures: Primary: The primary outcome is the change in glycated Hemoglobin (HbA1c)., 3 months|Change in HOMA-IR ., 3 months | Secondary: The secondary outcome is the change in expression of GRK2, 3 months
Sponsor/Collaborators: Sponsor: aya ramadan ashmawy sarhan
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 44
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2024-01
Completion Date: 2026-01
Results First Posted:
Last Update Posted: 2024-01-12
Locations:
URL: https://clinicaltrials.gov/show/NCT06203275